Harvard Bioscience (HBIO) Competitors

Harvard Bioscience (NASDAQ:HBIO) and Thermo Fisher Scientific (NYSE:TMO) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability.

Which has more volatility and risk, HBIO or TMO?

Harvard Bioscience has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500.

Does the MarketBeat Community prefer HBIO or TMO?

Thermo Fisher Scientific received 722 more outperform votes than Harvard Bioscience when rated by MarketBeat users. Likewise, 80.71% of users gave Thermo Fisher Scientific an outperform vote while only 71.15% of users gave Harvard Bioscience an outperform vote.

Company	Underperform	Outperform
Harvard Bioscience	Outperform Votes 370 71.15%	Underperform Votes 150 28.85%
Thermo Fisher Scientific	Outperform Votes 1092 80.71%	Underperform Votes 261 19.29%

Is HBIO or TMO more profitable?

Thermo Fisher Scientific has a net margin of 14.78% compared to Harvard Bioscience's net margin of -14.57%. Thermo Fisher Scientific's return on equity of 17.51% beat Harvard Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Harvard Bioscience	-14.57%	-4.64%	-2.40%
Thermo Fisher Scientific	14.78%	17.51%	8.52%

Which has stronger earnings & valuation, HBIO or TMO?

Thermo Fisher Scientific has higher revenue and earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harvard Bioscience	$91.40M	0.16	-$3.41M	-$1.32	-0.25
Thermo Fisher Scientific	$42.90B	3.50	$6.34B	$17.05	23.34

Does the media prefer HBIO or TMO?

In the previous week, Thermo Fisher Scientific had 54 more articles in the media than Harvard Bioscience. MarketBeat recorded 54 mentions for Thermo Fisher Scientific and 0 mentions for Harvard Bioscience. Thermo Fisher Scientific's average media sentiment score of 1.08 beat Harvard Bioscience's score of -0.21 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Overall Sentiment
Harvard Bioscience	Neutral
Thermo Fisher Scientific	Positive

Do institutionals & insiders believe in HBIO or TMO?

80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 9.0% of Harvard Bioscience shares are owned by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Do analysts rate HBIO or TMO?

Harvard Bioscience presently has a consensus target price of $3.00, suggesting a potential upside of 819.68%. Thermo Fisher Scientific has a consensus target price of $607.43, suggesting a potential upside of 52.66%. Given Harvard Bioscience's higher probable upside, equities research analysts clearly believe Harvard Bioscience is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harvard Bioscience	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.81

Summary

Thermo Fisher Scientific beats Harvard Bioscience on 15 of the 18 factors compared between the two stocks.